Obesity and surgical complications of pancreaticoduodenectomy: An observation study utilizing ACS NSQIP.

Abstract

BACKGROUND\nAn estimated 38% of US adults are obese. Obesity is associated with socioeconomic disparities and increased rates of comorbidities, and is a known risk factor for development of pancreatic cancer. As a fourth leading cause of death in the United States, pancreatic cancer is commonly treated with a pancreatico-duodenectomy (PD), or Whipple procedure. Data regarding the effects of obesity on post-operative complication rate primarily comes from specialized centers, however the results are mixed. Our aim is to elucidate the effects that obesity has on outcomes after PD for pancreatic head cancer using a national prospectively maintained clinical database.\n\n\nMETHOD\nThe 2010-2015 American College of Surgeons National Surgical Quality Improvement Project (ACS NSQIP) Participant Use Files (PUF) were used as the data source. We identified cases in which PD was performed (CPT code 48150) in the setting of a postoperative diagnosis of pancreatic cancer (ICD9 code 157.0). We excluded cases that had emergency admissions, BMI ≤18.5\u202fkg/m2, intraoperative wound classification of III or IV, and disseminated cancer. Cases with missing BMI, preoperative albumin, operative time, LOS data were also excluded. Multiple imputation for missing sex, race, functional status, and ASA classification using chained equations was performed.16 Patients that had BMI ≥30\u202fkg/m2 were considered obese, and patients with BMI <30\u202fkg/m2 were used as control.\n\n\nRESULTS\n3484 patients underwent pancreaticoduodenectomy for pancreatic cancer. 860 patients were identified as obese. Propensity score analysis was performed matching age, sex, race, functional status, presence of dyspnea, diabetes, hypertension, acute renal failure, dialysis dependence, ascites, steroid use, bleeding disorders, history of chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), weight loss, American Society of Anesthesiologists (ASA) classification, and preoperative albumin levels. After matching, obese patients had higher risk of 30-day postoperative complications compared to control, including organ space wound infections (OR 1.38, 95% CI 1.07-1.79, p\u202f=\u202f0.0128), returning to the operating room (OR 1.39, 95% CI 1.01-1.91, p\u202f=\u202f0.0461), failure to extubate for greater than 48\u202fh (OR 1.60, 95% CI 1.09-2.34, p\u202f=\u202f0.0153), death (OR 1.68, 95% CI 1.01-2.78, p\u202f=\u202f0.0453), septic shock (OR 2.22, 95% CI 1.46-3.38, p\u202f=\u202f0.0002), pulmonary embolism (OR 2.42, 95% CI 1.07-5.45, p\u202f=\u202f0.0332), renal insufficiency (OR 2.67, 95% CI 1.33-5.38, p\u202f=\u202f0.0058). Sensitivity analysis yielded similar results with the exception of risk for return to the operating room, death, and pulmonary embolism, P\u202f>\u202f.05.\n\n\nCONCLUSION\nIn this large observational study using a national clinical database, obese patients undergoing PD for head of pancreas cancer had increased risk of postoperative complications and mortality in comparison to controls.